New drug shows potential for blood cancer
(HealthDay)—A two-pronged immune-boosting drug could provide new hope for people stricken with multiple myeloma, a cancer of the blood and bone marrow, according to clinical trial findings.
View ArticleGhana suspends Ebola vaccine trial after 'guinea pig' backlash
Ghana has suspended a trial for an Ebola vaccine after complaints that locals were being needlessly used as "guinea pigs" in a country currently free of the deadly disease.
View ArticleIsolation and characterization of human hepatocytes and non-parenchymal liver...
University Medicine Berlin, Department for General, Visceral and Transplantation Surgery, led by Dr. Georg Damm (and Prof. Dr. Daniel Seehofer) have established a protocol for an uncomplicated...
View ArticleTekmira says Ebola drug unlikely to work in study
Drugmaker Tekmira said Friday that an experimental treatment for a strain of Ebola will probably fail in a clinical trial.
View ArticleVaccine for West Nile Virus enters human clinical trials
A clinical trial of a new investigational vaccine designed to protect against West Nile Virus infection will be sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of...
View ArticleImmune cell journey has bloody consequences
Immune cells that creep across blood vessels trigger potentially fatal bleeding in platelet-deficient mice, according to a report published in The Journal of Experimental Medicine. If the same is true...
View ArticleResearchers develop aerosolized vaccine that protects primates against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola. The...
View ArticleColor-blind? Whites aware of their bias better for modern race issues, says...
Some white Americans like to pat themselves on the back for being racially color-blind. But a new study published in the Journal of Experimental Social Psychology finds that whites aware of their...
View ArticleHow GPR40, a known receptor for dietary fatty acids, may protect from...
Osteoarthritis (OA) is one of the most common age-related degenerative joint concerns. Although articular cartilage degradation is its main feature, this disease induces whole-joint damage...
View ArticleStopping malaria in its tracks
A new drug acts as a roadblock for malaria, curing mice of established infection, according to a study in The Journal of Experimental Medicine. Treatment was not associated with obvious side effects,...
View ArticlePenn Vet study shows immune cells in the skin remember and defend against...
Just as the brain forms memories of familiar faces, the immune system remembers pathogens it has encountered in the past. T cells with these memories circulate in the blood stream looking for sites of...
View ArticleMalaria's key to the liver uncovered
Scientists uncover a port of liver entry for malaria parasites in a report published in The Journal of Experimental Medicine. If these results hold up in humans, drugs that target this entry protein...
View ArticleData analyses back Sanofi dengue vaccine: study
A dengue vaccine candidate by French drugmaker Sanofi protects more than three quarters of participants, an analysis found Monday.
View ArticleExperimental MERS vaccine shows promise in animal studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who...
View ArticleNew drug effectively lowers levels of triglycerides
(HealthDay)—An experimental drug, ISIS 304801, can lower triglyceride levels by as much as 71 percent, according to study results published in the July 30 issue of the New England Journal of Medicine.
View ArticleImproved memory thanks to irregular sleep-wake patterns
If you've had a good night's sleep, you are mentally more alert and your memory works more reliably. During sleep, a part of our forebrain called the prefrontal cortex remains active. It ensures that...
View ArticleNovavax: Early study indicates its vaccine effective vs. RSV
Early research in older adults found an experimental vaccine prevented nearly two-thirds of serious cases of a common, seasonal respiratory virus that annually kills thousands of vulnerable...
View ArticleVaccine combo shows promise against common, dangerous infection
Researchers report they are closer to finding a vaccine for respiratory syncytial virus (RSV), a common illness that few recognize by name but one that's a major cause of lower respiratory infection in...
View ArticleEpstein-Barr virus vaccine elicits potent neutralizing antibodies in animals
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and their collaborators have developed an experimental, nanoparticle-based...
View ArticleDegenerating neurons respond to gene therapy treatment for Alzheimer's disease
Degenerating neurons in patients with Alzheimer's disease (AD) measurably responded to an experimental gene therapy in which nerve growth factor (NGF) was injected into their brains, report researchers...
View Article